**RFK Jr. remains HHS Secretary with strong ongoing White House alignment more than a year into the role.** As of September 2026, he continues directing agency staffing increases in political appointees, MAHA-focused policy revisions on vaccines, food safety, and chronic disease, plus fiscal year 2026 budget testimony before Congress. Recent leadership reorganizations and public announcements show active engagement rather than any exit signals. Democratic calls for resignation and external criticism over agency changes have not altered presidential support or produced procedural moves toward removal. Traders price the low likelihood of departure by October 31 at roughly 6-7% because no credible developments—such as confirmed resignation announcements, Senate actions, or White House statements—indicate an imminent change before the resolution window closes. Historical patterns of cabinet stability in aligned administrations further support the current implied probability.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedAn announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Market Opened: Sep 3, 2026, 9:28 AM ET
Resolver
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...**RFK Jr. remains HHS Secretary with strong ongoing White House alignment more than a year into the role.** As of September 2026, he continues directing agency staffing increases in political appointees, MAHA-focused policy revisions on vaccines, food safety, and chronic disease, plus fiscal year 2026 budget testimony before Congress. Recent leadership reorganizations and public announcements show active engagement rather than any exit signals. Democratic calls for resignation and external criticism over agency changes have not altered presidential support or produced procedural moves toward removal. Traders price the low likelihood of departure by October 31 at roughly 6-7% because no credible developments—such as confirmed resignation announcements, Senate actions, or White House statements—indicate an imminent change before the resolution window closes. Historical patterns of cabinet stability in aligned administrations further support the current implied probability.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated


Beware of external links.
Beware of external links.
Frequently Asked Questions